Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Lifestyle brand Stanley 1913 adapts its marketing for the AI search era
The marketing it was doing worked well, but only for a human audience. The brand needed different approaches to ensure it was picked up by the AI platforms.
Walmart finally lets advertisers exclude certain search terms
Walmart Connect said it would give advertisers the ability to exclude specific search terms for sponsored-products campaigns through “negative keywords.”
Build or buy: Inside indie agency Mod Op’s AI infrastructure
Mod Op is betting that building its own AI infrastructure can deliver more value than simply licensing off-the-shelf tools.